207940 (207940) News
Follow 207940 (207940) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 31 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Samsung Biologics Wins 93.5 Billion Won Order
Samsung Biologics has secured a new order valued at 93.5 billion South Korean won.
EQUITY | Oct 02, 2026, 07:20 AM UTC
L
South Korean shares set for biggest quarterly drop since early 2020
Round-up of South Korean financial markets:** South Korean shares erased early gains to trade lower on Wednesday, weighed down by concerns over high bond yields, and were set for their biggest quarterly drop in 6-1/2 yea
EQUITY | Sep 30, 2026, 03:10 AM UTC
L
South Korean shares extend losses as high bond yields weigh
Round-up of South Korean financial markets:** South Korean shares fell for a second straight session on Tuesday, weighed by concerns over high bond yields, while investors stood on the sidelines ahead of major events tha
EQUITY | Sep 29, 2026, 07:08 AM UTC
H
South Korean shares flat as chip gains balance broader weakness
Round-up of South Korean financial markets:** South Korean shares were little changed on Tuesday as strength in semiconductor stocks offset weakness elsewhere, while investors awaited domestic trade data and US chipmaker
EARNINGS | Sep 29, 2026, 02:16 AM UTC
L
South Korean shares fall more than 2% as chipmakers drop
Round-up of South Korean financial markets:** South Korean shares fell more than 2% on Monday as chipmakers dropped amid worries about high bond yields, in catch-up trading following a holiday break.** The benchmark KOSP
EQUITY | Sep 28, 2026, 01:34 AM UTC
L
South Korean shares close at 2-month high as chipmakers jump
Round-up of South Korean financial markets:** South Korean shares rose on Wednesday for a fourth consecutive session to close at a two-month high, led by gains in chipmakers on an AI rally.** The benchmark KOSPI KRX:KOSP
EQUITY | Sep 23, 2026, 06:56 AM UTC
L
South Korean shares give up early gains as investors head for holidays
Round-up of South Korean financial markets:** South Korean shares gave up early gains to trade little changed on Wednesday as investors turned risk-averse ahead of a long holiday break.** The benchmark KOSPI KRX:KOSPI wa
EQUITY | Sep 23, 2026, 02:34 AM UTC
L
South Korean shares end lower as rising bond yields weigh
Round-up of South Korean financial markets:** South Korean shares closed lower after a session of volatile trade on Tuesday, as investors remained wary of rising bond yields.** The benchmark KOSPI KRX:KOSPI fell 57.12 po
EQUITY | Sep 15, 2026, 06:52 AM UTC
L
South Korean shares recoup early losses as chipmakers rebound
Round-up of South Korean financial markets:** South Korean shares clawed back early losses on Tuesday, as bargain hunting in chip stocks followed a three-session slide that culminated in a more than 3% drop in the KOSPI
EQUITY | Sep 15, 2026, 02:00 AM UTC
L
South Korea shares retreat on AI concerns, set for longer trading hours
Round-up of South Korean financial markets:** South Korean shares fell on Monday after Anthropic PBC and OpenAI raised their voices to put the brakes on artificial intelligence development. The won strengthened, while th
EQUITY | Sep 14, 2026, 03:14 AM UTC
L
Samsung Biologics announces pharmaceutical contract manufacturing agreement
EQUITY | Sep 10, 2026, 07:12 AM UTC
L
South Korea shares rise on chip rally
South Korea shares rise on chip rally
EQUITY | Aug 31, 2026, 08:00 AM UTC
H
Samsung Biologics to buy Polypeptide Group shares for 2.7 trln won
Samsung Biologics and Samsung Peptide will buy shares in Polypeptide Group AG worth 2.7 trln won.
EQUITY | Aug 31, 2026, 07:27 AM UTC
L
Samsung acquisition announced; aims to complete by November
Samsung announced an acquisition in July, aiming to complete the deal by November.
MNA | Aug 31, 2026, 05:48 AM UTC
M
Samsung Biologics plans PolyPeptide takeover bid in September
Samsung Biologics plans to launch a takeover bid for PolyPeptide in September.
MNA | Aug 31, 2026, 05:47 AM UTC
M
Samsung Peptide plans takeover bid for Swiss PolyPeptide
Samsung Peptide plans to launch a takeover bid for Swiss PolyPeptide.
MNA | Aug 31, 2026, 05:12 AM UTC
L
Samsung Biologics publishes PolyPeptide tender offer prospectus
Samsung Biologics has published a prospectus for PolyPeptide’s public tender offer.
EQUITY | Aug 31, 2026, 05:00 AM UTC
L
South Korean shares track regional losses after Warsh's hawkish remarks
South Korean shares track regional losses after Warsh's hawkish remarks
EQUITY | Aug 31, 2026, 01:25 AM UTC
L
South Korea shares mark second weekly decline
South Korea shares mark second weekly decline
EQUITY | Aug 28, 2026, 07:02 AM UTC
L
South Korea shares to log second weekly decline
South Korea shares to log second weekly decline
EQUITY | Aug 28, 2026, 02:31 AM UTC
M
Samsung Biologics seeks over $2B funding for PolyPeptide deal
Samsung Biologics seeks to raise over $2B to fund a PolyPeptide deal and expansion.
EQUITY | Aug 28, 2026, 02:21 AM UTC
M
Samsung Biologics to buy PolyPeptide Group for about $2 billion
Samsung Biologics plans to acquire PolyPeptide Group for about $2 billion.
EQUITY | Aug 28, 2026, 12:17 AM UTC
L
Samsung Biologics to List New Shares in November
Samsung Biologics to List New Shares in November
EQUITY | Aug 27, 2026, 11:48 PM UTC
L
Proceeds plan: stake purchase and facility investment
Samsung Biologics will use proceeds for a stake purchase and facility investment.
EQUITY | Aug 27, 2026, 11:47 PM UTC
M
Samsung Biologics to raise about KRW 3T via rights issue
Samsung Biologics plans to raise about KRW 3T through a rights issue.
EQUITY | Aug 27, 2026, 11:46 PM UTC
M
Samsung Biologics to acquire PolyPeptide Group for KRW2.706T
Samsung Biologics plans to acquire 100% of PolyPeptide Group for KRW2.706T.
MNA | Aug 27, 2026, 11:44 PM UTC
L
Samsung Biologics announces KRW 3T rights offering for expansion
Samsung Biologics announced a KRW 3T rights offering to fund its next-phase expansion.
EQUITY | Aug 27, 2026, 11:25 PM UTC
M
Samsung Biologics plans to allocate KRW2.71T for PolyPeptide acquisition
Plans to allocate about KRW2.71T of offering proceeds to buy PolyPeptide Group and KRW290B for expansion of Bio Campus II.
MNA | Aug 27, 2026, 11:25 PM UTC
L
Samsung Biologics announces KRW 3 trillion rights offering
Samsung Biologics announced a KRW 3 trillion rights offering to fund its next-phase expansion.
EQUITY | Aug 27, 2026, 11:00 PM UTC
M
Samsung Biologics to sell 294.8 billion won new shares
Samsung Biologics Co. plans to sell 294.8 billion won in new shares.
EQUITY | Aug 27, 2026, 10:54 PM UTC
H
South Korean shares rise on cautious optimism ahead of Nvidia earnings
South Korean shares rise on cautious optimism ahead of Nvidia earnings
EARNINGS | Aug 26, 2026, 07:18 AM UTC